Croda International (LSE:CRDA) reported first-quarter 2026 sales of £431 million, representing a 1% increase at constant currency and broadly meeting expectations despite a tough comparison with the prior year. Growth across its Consumer Care division—particularly in Beauty Actives, fragrances and flavours, and home care—helped offset weaker performance in Life Sciences, where Crop Protection revenues declined by 8% at constant currency. Industrial Specialties also experienced slight pressure on volumes during the period.
From a regional perspective, Latin America delivered the strongest performance, supported by steady agricultural demand and robust Consumer Care activity. North America, however, lagged as crop protection markets normalised, compounded by weather-related disruption and softer consumer demand. The company noted that ongoing tensions in the Middle East have not materially affected operations to date. Management reiterated its full-year 2026 guidance and confirmed that its transformation programme remains on track to deliver margin expansion and improved returns, although currency movements are expected to reduce reported operating profit by approximately £4 million.
Croda’s overall outlook reflects a balance between stable financial fundamentals—such as manageable leverage and positive cash generation—and favourable technical momentum, against the backdrop of a relatively high valuation multiple. Execution risks remain, highlighted by exceptional charges and uneven performance across segments, even as guidance improves and transformation initiatives progress.
More about Croda International
Croda International is a UK-based specialty chemicals company providing innovative ingredients and technologies across consumer care, life sciences, and industrial markets. Its offerings include beauty actives, personal and home care ingredients, fragrances and flavours, as well as solutions for pharmaceuticals, crop protection, and seed enhancement, serving a global customer base.
Leave a Reply